Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders

Rhea-AI Summary

Surface Oncology (NASDAQ: SURF) has announced that its 2020 Annual Meeting of Stockholders will be held virtually due to ongoing COVID-19 concerns. The meeting is scheduled for June 10, 2020, at 11:00 a.m. EDT. Only stockholders who were on record as of April 15, 2020, can participate. Registration is required before June 8, 2020, to access the virtual meeting. All stockholders are encouraged to submit their votes in advance or vote online during the meeting. This decision prioritizes health and safety amidst the pandemic.

Positive

• The 2020 Annual Meeting being held virtually allows for broader participation due to safety concerns.
• Encourages broader engagement from stockholders who might not be able to attend in person.

Negative

• None.

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that its 2020 Annual Meeting of Stockholders has been changed to a virtual meeting as a result of continuing concerns surrounding the COVID-19 pandemic. The meeting will still be held on Wednesday, June 10, 2020 at 11:00 a.m. EDT, as previously announced. Stockholders will only be able to participate in this year’s Annual Meeting via the virtual meeting. This change is reflective of the public health impact of the COVID-19 pandemic, government restrictions limiting the size of gatherings, and supporting the health and well-being of Surface Oncology’s stockholders, directors and employees, and their communities.

Stockholders are entitled to participate in and vote at the Annual Meeting if they were a stockholder at the close of business on April 15, 2020, the record date, or hold a legal proxy for the meeting provided by the stockholder’s bank, broker or nominee as of such record date. To access, participate in and vote at the Annual Meeting, stockholders must register in advance at the Meeting Registration Website (https://viewproxy.com/SurfaceOncology/2020) prior to the deadline of 11:59 p.m. EDT on June 8, 2020. Upon completing registration, eligible participants will receive further instructions via email, including unique links that will allow such eligible participants to access the meeting. Eligible participants who have difficulty accessing the virtual meeting or the Meeting Registration Website may call the technical support number provided. 

Please note that the proxy card included with the proxy materials previously distributed will not be updated to reflect the change in location and may continue to be used to vote your shares in connection with the Annual Meeting.

All stockholders — whether attending the Annual Meeting or not — are encouraged to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials. Stockholders may also vote online during the Annual Meeting by following the instructions available on the Meeting Registration Website.

About Surface Oncology:

Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), a clinical-stage collaboration with Novartis targeting CD73 (NZV930), and two preclinical programs, each focused primarily on activating natural killer cells (via targeting CD112R, also known as PVRIG) or depleting regulatory T cells (via targeting CCR8). Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies. For more information, please visit www.surfaceoncology.com.

Contacts:

Investors
Matt Lane
matt@gilmartinir.com
617-901-7698

Media
Tom Donovan
tom@tenbridgecommunications.com
857-559-3397

FAQ

What date is the Surface Oncology Annual Meeting?

The Surface Oncology Annual Meeting is scheduled for June 10, 2020.

Why has the Surface Oncology Annual Meeting changed to a virtual format?

The Annual Meeting changed to a virtual format due to ongoing concerns surrounding the COVID-19 pandemic.

What is the record date for stockholders to participate in the Surface Oncology Annual Meeting?

The record date for stockholders to participate is April 15, 2020.

How can stockholders register for the Surface Oncology Annual Meeting?

Stockholders can register for the Annual Meeting at the Meeting Registration Website before June 8, 2020.

Can stockholders vote online during the Surface Oncology Annual Meeting?

Yes, stockholders can vote online during the Annual Meeting by following the instructions available on the Meeting Registration Website.